EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours

Ling Ni iD

Clinical and Translational Medicine · 2024-08 · 14 (8)

DOI: 10.1002/ctm2.1817 ↗

At a glance

Übersichtsarbeit in Clinical and Translational Medicine, published online on 2024-08-21. Written by Ling Ni. Institution: Institute for Immunology and School of Basic Medicine, Tsinghua University, Beijing, China. Major MEDLINE topics: Neoplastic Stem Cells. Cited 32 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

In situations involving continuous exposure to antigens, such as chronic infections or cancer, antigen‐specific CD8 + T cells can become dysfunctional or exhausted. This change is marked by increased expression levels of inhibitory receptors (PD‐1 and Tim‐3). Stem‐like progenitor exhausted (Tpex) cells, a subset of exhausted cells that express TCF‐1 and are mainly found in the lymph nodes, demonstrate the ability to self‐renew and exhibit a high rate of proliferation. Tpex cells can further differentiate into transitional intermediate exhausted (Tex‐int) cells and terminally exhausted (Tex‐term) cells. Alternatively, they can directly differentiate into Tex‐term cells. Tpex cells are the predominant subset that respond to immune checkpoint inhibitors (ICI), making them a prime candidate for improving the efficacy of ICI therapy. This review article aimed to present the latest developments in the field of Tpex formation, expansion, and differentiation in the context of cancer, as well as their responses to ICIs in cancer immunotherapy. Consequently, it may be possible to develop novel treatments that exclusively target Tpex cells, thus improving overall treatment outcomes. Key points Tpex cells are located in lymph nodes and TLS. Several pathways control the differentiation trajectories of Tpex cells, including epigenetic factors, transcription factors, cytokines, age, sex, etc.

Subjects

MeSH terms (MEDLINE)

Neoplastic Stem CellsHumansNeoplasmsCell DifferentiationCD8-Positive T-Lymphocytes

Author keywords

CD8+ T cellsTex‐int cellsTex‐term cellsTpex cellscancerimmune checkpoint inhibitors

Authors and institutions

  • Institute for Immunology and School of Basic Medicine, Tsinghua University, Beijing, China.

ORCID profiles: Ling Ni

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Cite

APA

Ni, L. (2024). Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours. Clinical and Translational Medicine, 14(8). https://doi.org/10.1002/ctm2.1817

Vancouver

Ni L. Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours. Clinical and Translational Medicine. 2024;14(8). doi:10.1002/ctm2.1817

BibTeX
@article{Ni2024,
  author = {Ni, Ling},
  title = {Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {8},
  doi = {10.1002/ctm2.1817}
}
Start for free →